Myasthenic Syndromes, Congenital
Also known as: Congenital Myasthenic Syndrome / Congenital Myasthenia (CM) / Congenital Myasthenic Syndromes / Congenital Myasthenia / Congenital myasthenic syndrome (disorder)
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB00545 | Pyridostigmine | A cholinesterase inhibitor used for symptomatic treatment of myasthenia gravis and congenital myasthenic syndromes and to reverse neuromuscular blockade by nondepolarizing muscle relaxants. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB00545 | Pyridostigmine | Acetylcholinesterase | target |
| DB00545 | Pyridostigmine | Cholinesterase | target |
| DB00545 | Pyridostigmine | Acetylcholinesterase | enzyme |
| DB00545 | Pyridostigmine | Cholinesterase | enzyme |
| DB00545 | Pyridostigmine | Cytochrome P450 3A4 | enzyme |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB01001 | Albuterol | 1 | Completed | 1 |
| DB01364 | Ephedrine | 1 / 2 | Unknown Status | 1 |
| DB11640 | Amifampridine | 3 | Completed | 1 |
| DB11640 | Amifampridine | Not Available | Approved for Marketing | 1 |
| DB11640 | Amifampridine | Not Available | No Longer Available | 4 |